PCM - Pharma Consulting & Management GmbH > In-/Out-Licensing > Ethical > Somatostatin acetate - available for licensing

Ethical pharmaceuticals

Somatostatin acetate 3mg

Somatostatin acetate, a synthetic hormone identical in structure and effect to the native hormone.


Severe, acute gastroduodenal ulcer bleeding,

Severe, acute bleeding in acute erosive or hemorrhagic gastritis,

Prophylaxis for postoperative pancreatic complications following pancreatic surgery,

Adjuvant therapy for inhibiting the secretion of severe secretory postoperative fistulae of the pancreas and upper small intestine.

Pharmaceutical form and presentation

Lyophylisate to prepare a solution for infusion.

Ampoule with 3mg somatostatin acetate.


Starting dose by intravenous injection.

Intravenous infusion.

Produced in

European Union.

Available countries

On request.


Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic informationand are not usage instructions.

Please observe the officially approved product information.